StockData
ADC Therapeutics SA logo

ADC Therapeutics SA (ADCT) bonds

ADCTNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$1.35+0.10 (+8.00%)

Close on Nov 17, 2026Market cap $172.35MP/E –Yield –

Debt

Borrowings on the balance sheet, Sep 30, 2026

ADC Therapeutics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in ADC Therapeutics's 10-Q for the period ended Jun 30, 2026

ADC Therapeutics's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeDrawn
Loan Agreement$175.00M$124.74M

See a number that looks wrong?